News
2023-10-19
Cellectricon receives CIR (French Research Tax Credit) accreditation
MÖLNDAL, SWEDEN Cellectricon AB, a services provider dedicated to advancing neuroscience drug discovery, today announced that it has received CIR...
News
2023-09-26
Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services
Mölndal, Sweden Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, today announced the launch of a new service...
News
2023-02-14
Delix Therapeutics partners with Cellectricon, Expressive Neuroscience and expands science team to accelerate drug discovery and translatability
We’re excited to be working with Delix Therapeutics and support their development of neuroplasticity-promoting therapeutics! At Cellectricon, we solve our...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

News
2023-01-31
Cellectricon strengthens IP portfolio – Receives “Intention to Grant” from the European Patent Office
Cellectricon AB, a leading provider of neurobiology in vitro research services, today announced that the company received notice of intention...
News
2021-06-03
Cellectricon receives funding from Takeda’s open innovation platform
March 3, 2021 Cellectricon, a leading provider of neurobiology in vitro research services, is delighted to announce the initiation of...
News
2021-05-27
Dr. Christian Vægter joins Cellectricon’s advisory board
Cellectricon has appointed Dr. Christian Vægter, Associate Professor and research group leader at Aarhus University, to its Scientific Advisory Board....

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

News
2020-07-02
Dr. Franziska Denk joins Cellectricon’s advisory board
Cellectricon has appointed Dr. Franziska Denk, Lecturer at the Wolfson Centre for Age-Related Diseases, King’s College London, to its scientific...
News
2020-06-04
Advancing pain research through scientific exchange
During the current COVID-19 pandemic many of our fellow researchers see disruption in their work and are prevented from sharing...
News
2020-05-20
Cellectricon’s new neuroinflammation discovery services offer advanced insight into chronic pain
Mölndal, Sweden Cellectricon, a collaborative services provider dedicated to advancing drug discovery and research in the areas of chronic pain...